Quantitative Systematic Strategies LLC Apellis Pharmaceuticals, Inc. Transaction History

Quantitative Systematic Strategies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$40.8 - $57.39 $311,140 - $437,656	-7,626 Reduced 53.82%	6,543 $281,000
Q4 2020 Feb 09, 2021	BUY	$30.79 - $57.2 $203,675 - $378,378	6,615 Added 87.57%	14,169 $810,000
Q3 2020 Nov 09, 2020	BUY	$25.89 - $33.65 $195,573 - $254,192	7,554 New	7,554 $228,000
Q1 2020 May 06, 2020	SELL	$17.91 - $44.33 $205,051 - $507,534	-11,449 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$22.1 - $30.8 $253,022 - $352,629	11,449 New	11,449 $351,000
Q1 2018 May 04, 2018	SELL	$14.01 - $26.02 $204,349 - $379,527	-14,586 Closed	0 $0
Q4 2017 Feb 01, 2018	BUY	$12.71 - $21.7 $185,388 - $316,516	14,586	14,586 $317,000

301

111M

2.63M

845K

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $2.61B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.